Abstract
Owing to the serious clinical consequences associated with acquisition of resistance to current antiretroviral drugs, discovery of new drug targets and development of novel anti-HIV-1 therapeutic agents have become a high research priority. The late stages of HIV-1 replication involve the processes of assembly, budding and maturation, and comprise several new potential therapeutic targets which have not (yet) been targeted by any of the antiretroviral drugs approved at present. The structural protein Gag plays a central role in these stages through its different regions and mature Gag proteins working in concert. In this article, we highlight a number of steps in the late stages of HIV-1 replication that represent promising targets for drug discovery. Recent progress in development of related inhibitors targeting at CA, zinc fingers of NC, p6-Tsg101 interaction, lipid rafts of plasma membrane, proteolytic cleavage sites in Gag and gp160 processing is also reviewed.
Keywords: HIV-1, assembly, budding, maturation, Gag, Matrix, Nucleocapsid, Capsid, immunodeficiency, causative agent, UNAIDS/WHO, Epidemic, vaccine, drug, antiretroviral, viral replication cycle, noninfectious, polyprotein, cytoplasmic, RNA genome, capsid antigen, glycoprotein, encapsidation, multimerization, hexameric lattice, mutations, zinc-finger, globular structure, virus infectivity, myristic acid, phospholipids, phosphatidylinositol, acyl chain, antiviral, ribosomes, multivesicular bodys, amino-acid, high-resolution structural, peptides, enzymes, rational drug, silicon, spectroscopy, hydrophobic cavity, isolates, Inhibitors, glycineamide, cyclophilin, oxygen, isoxazole, sulfamide, binding affinity, disulfide bond, half-life, reduction, solubility, cell toxicity, covalent, bioavailability, aromatic ring, tryptophan, secondary screening, Betulinic Acid Derivatives, dimethylsuccinyl, drug-resistant HIV-1, virology
Current Medicinal Chemistry
Title: New Therapeutic Approaches Targeted at the Late Stages of the HIV-1 Replication Cycle
Volume: 18 Issue: 1
Author(s): Yan Jiang, Xinyong Liu and Erik De Clercq
Affiliation:
Keywords: HIV-1, assembly, budding, maturation, Gag, Matrix, Nucleocapsid, Capsid, immunodeficiency, causative agent, UNAIDS/WHO, Epidemic, vaccine, drug, antiretroviral, viral replication cycle, noninfectious, polyprotein, cytoplasmic, RNA genome, capsid antigen, glycoprotein, encapsidation, multimerization, hexameric lattice, mutations, zinc-finger, globular structure, virus infectivity, myristic acid, phospholipids, phosphatidylinositol, acyl chain, antiviral, ribosomes, multivesicular bodys, amino-acid, high-resolution structural, peptides, enzymes, rational drug, silicon, spectroscopy, hydrophobic cavity, isolates, Inhibitors, glycineamide, cyclophilin, oxygen, isoxazole, sulfamide, binding affinity, disulfide bond, half-life, reduction, solubility, cell toxicity, covalent, bioavailability, aromatic ring, tryptophan, secondary screening, Betulinic Acid Derivatives, dimethylsuccinyl, drug-resistant HIV-1, virology
Abstract: Owing to the serious clinical consequences associated with acquisition of resistance to current antiretroviral drugs, discovery of new drug targets and development of novel anti-HIV-1 therapeutic agents have become a high research priority. The late stages of HIV-1 replication involve the processes of assembly, budding and maturation, and comprise several new potential therapeutic targets which have not (yet) been targeted by any of the antiretroviral drugs approved at present. The structural protein Gag plays a central role in these stages through its different regions and mature Gag proteins working in concert. In this article, we highlight a number of steps in the late stages of HIV-1 replication that represent promising targets for drug discovery. Recent progress in development of related inhibitors targeting at CA, zinc fingers of NC, p6-Tsg101 interaction, lipid rafts of plasma membrane, proteolytic cleavage sites in Gag and gp160 processing is also reviewed.
Export Options
About this article
Cite this article as:
Jiang Yan, Liu Xinyong and De Clercq Erik, New Therapeutic Approaches Targeted at the Late Stages of the HIV-1 Replication Cycle, Current Medicinal Chemistry 2011; 18 (1) . https://dx.doi.org/10.2174/092986711793979751
DOI https://dx.doi.org/10.2174/092986711793979751 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Drug Discoveries Towards Kv1.5 Potassium Channel
Current Topics in Medicinal Chemistry Targeting IAPs as An Approach to Anti-Cancer Therapy
Current Topics in Medicinal Chemistry The Effects of Obesity on Drug Metabolism in Children
Drug Metabolism Letters TGF-β Pathway as a Therapeutic Target in Bone Metastases
Current Pharmaceutical Design Alternatives to Conventional Vaccines - Mediators of Innate Immunity
Current Drug Targets Early Aged T-Cells in Immune-Mediated Diseases
Current Immunology Reviews (Discontinued) The Pathophysiology of Heme in the Brain
Current Alzheimer Research Continuous Positive Airway Pressure Treatment in Patients with Sleep Apnoea: Does it Really Improve Glucose Metabolism?
Current Diabetes Reviews Novel Concepts in the Pathogenesis and Management of Pediatric Hypertension
Current Pediatric Reviews Current Problems with Non-Specific COX Inhibitors
Current Pharmaceutical Design Putative Mechanisms of Action and Clinical Use of Lithium in Children and Adolescents: A Critical Review
Current Neuropharmacology Current Treatments of Muco-Cutaneous Herpes Simplex Virus Infections
Current Medicinal Chemistry - Anti-Infective Agents Potential Role of (-)-Epigallocatechin-3-Gallate (EGCG) in the Secondary Prevention of Alzheimer Disease
Current Drug Targets Gene Expression Profiling Analysis to Identify Key Genes and Underlying Mechanisms in Meniscus of Osteoarthritis Patients
Combinatorial Chemistry & High Throughput Screening Coenzyme Q10 for Patients with Parkinson's Disease: A Systematic Review and Meta-Analysis
CNS & Neurological Disorders - Drug Targets Aliskiren, a Direct Renin Inhibitor, in Clinical Practice: A New Approach in the Treatment of Hypertension
Current Vascular Pharmacology Dry Eyes in Rheumatic Disease
Current Rheumatology Reviews An Overview of Parkinsons Disease and the Cannabinoid System and Possible Benefits of Cannabinoid-Based Treatments
Current Medicinal Chemistry Angiotensin-Converting Enzyme - New Insights into Structure, Biological Significance and Prospects for Domain-Selective Inhibitors
Current Enzyme Inhibition Insulin-like Growth Factor: Current Concepts and New Developments in Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery